> As reported by Financial Times, funds have made an estimated $2.1 billion over the past year by shorting U.S.-listed NuScale Power, Nano Nuclear and Sam Altman-backed Oklo, according to S3 Partners data. The gains come as the sector's earlier rally gives way to concerns over limited revenue, persistent losses and the long timelines required to commercialise small modular reactor technology.
k310•1h ago
> As reported by Financial Times, funds have made an estimated $2.1 billion over the past year by shorting U.S.-listed NuScale Power, Nano Nuclear and Sam Altman-backed Oklo, according to S3 Partners data. The gains come as the sector's earlier rally gives way to concerns over limited revenue, persistent losses and the long timelines required to commercialise small modular reactor technology.